Lupus Erythematosus, Systemic Clinical Trial
— OASISOfficial title:
Mobile Study to Measure and Predict Lupus Disease Activity Using Digital Signals
NCT number | NCT04449653 |
Other study ID # | MEASURE |
Secondary ID | |
Status | Recruiting |
Phase | |
First received | |
Last updated | |
Start date | April 28, 2020 |
Est. completion date | June 1, 2021 |
OASIS: A mobile study to measure and predict lupus (SLE) disease activity using digital signals The OASIS study is exploring how patient reported data and digital biomarkers, like activity level and heart rate variability, can be used to predict changes in lupus disease activity. You may receive a Withings Steel HR smartwatch as part of this study. The purpose of this study is to look for factors that affect lupus disease activity and potentially predict lupus flares through non-clinical tests
Status | Recruiting |
Enrollment | 300 |
Est. completion date | June 1, 2021 |
Est. primary completion date | December 31, 2020 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Female or male age 18 or older - Participant is currently not enrolled in another study - Able to understand the requirements of the study, provide written informed consent, including consent for the use and disclosure of research-related health information, and comply with the study data collection procedures Exclusion Criteria: - NOT able to understand the requirements of the study, provide written informed consent, including consent for the use and disclosure of research-related health information, and comply with the study data collection procedures - Known to be pregnant |
Country | Name | City | State |
---|---|---|---|
United States | Ryan Newhardt | Oklahoma City | Oklahoma |
Lead Sponsor | Collaborator |
---|---|
Progentec Diagnostics, Inc. |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | OASIS Baseline Questionnaire | Basic Health Information and SLE-specific questions | Baseline, entered only upon enrollment | |
Primary | OASIS Wellness and Disease Questionnaire | Basic Health Information and Systemic Lupus Erythematosus-specific questions over the time span of a week | Week two | |
Primary | OASIS Wellness and Disease Questionnaire | Basic Health Information and Systemic Lupus Erythematosus-specific questions over the time span of a week | Week three | |
Primary | OASIS Wellness and Disease Questionnaire | Basic Health Information and Systemic Lupus Erythematosus-specific questions over the time span of a week | Week four | |
Primary | OASIS Wellness and Disease Questionnaire | Basic Health Information and Systemic Lupus Erythematosus-specific questions over the time span of a week | Week five | |
Primary | OASIS Wellness and Disease Questionnaire | Basic Health Information and Systemic Lupus Erythematosus-specific questions over the time span of a week | Week six | |
Primary | OASIS Wellness and Disease Questionnaire | Basic Health Information and Systemic Lupus Erythematosus-specific questions over the time span of a week | Week seven | |
Primary | OASIS Wellness and Disease Questionnaire | Basic Health Information and Systemic Lupus Erythematosus-specific questions over the time span of a week | Week eight | |
Primary | OASIS Wellness and Disease Questionnaire | Basic Health Information and Systemic Lupus Erythematosus-specific questions over the time span of a week | Week nine | |
Primary | OASIS Wellness and Disease Questionnaire | Basic Health Information and Systemic Lupus Erythematosus-specific questions over the time span of a week | Week ten | |
Primary | OASIS Wellness and Disease Questionnaire | Basic Health Information and Systemic Lupus Erythematosus-specific questions over the time span of a week | Week eleven | |
Primary | OASIS Wellness and Disease Questionnaire | Basic Health Information and Systemic Lupus Erythematosus-specific questions over the time span of a week | Week twelve | |
Primary | OASIS Wellness and Disease Questionnaire | Basic Health Information and Systemic Lupus Erythematosus-specific questions over the time span of a week | Week thirteen | |
Primary | OASIS Wellness and Disease Questionnaire | Basic Health Information and Systemic Lupus Erythematosus-specific questions over the time span of a week | Week fourteen | |
Primary | OASIS Wellness and Disease Questionnaire | Basic Health Information and Systemic Lupus Erythematosus-specific questions over the time span of a week | Week fifteen | |
Primary | OASIS Wellness and Disease Questionnaire | Basic Health Information and Systemic Lupus Erythematosus-specific questions over the time span of a week | Week sixteen | |
Primary | OASIS Wellness and Disease Questionnaire | Basic Health Information and Systemic Lupus Erythematosus-specific questions over the time span of a week | Week seventeen | |
Primary | OASIS Wellness and Disease Questionnaire | Basic Health Information and Systemic Lupus Erythematosus-specific questions over the time span of a week | Week eighteen | |
Primary | OASIS Wellness and Disease Questionnaire | Basic Health Information and Systemic Lupus Erythematosus-specific questions over the time span of a week | Week nineteen | |
Primary | OASIS Wellness and Disease Questionnaire | Basic Health Information and Systemic Lupus Erythematosus-specific questions over the time span of a week | Week twenty | |
Primary | OASIS Wellness and Disease Questionnaire | Basic Health Information and Systemic Lupus Erythematosus-specific questions over the time span of a week | Week twenty-one | |
Primary | OASIS Wellness and Disease Questionnaire | Basic Health Information and Systemic Lupus Erythematosus-specific questions over the time span of a week | Week twenty-two | |
Primary | OASIS Wellness and Disease Questionnaire | Basic Health Information and Systemic Lupus Erythematosus-specific questions over the time span of a week | Week twenty-three | |
Primary | OASIS Wellness and Disease Questionnaire | Basic Health Information and Systemic Lupus Erythematosus-specific questions over the time span of a week | Week twenty-four | |
Primary | OASIS Wellness and Disease Questionnaire | Basic Health Information and Systemic Lupus Erythematosus-specific questions over the time span of a week | Week twenty-five | |
Primary | OASIS Wellness and Disease Questionnaire | Basic Health Information and Systemic Lupus Erythematosus-specific questions over the time span of a week | Week twenty-six | |
Primary | Short Form, 36 question form | 36 questions asking individuals questions about their general health and wellness, not disease-specific | Month one | |
Primary | Short Form, 36 question form | 36 questions asking individuals questions about their general health and wellness, not disease-specific | Month two | |
Primary | Short Form, 36 question form | 36 questions asking individuals questions about their general health and wellness, not disease-specific | Month three | |
Primary | Short Form, 36 question form | 36 questions asking individuals questions about their general health and wellness, not disease-specific | Month four | |
Primary | Short Form, 36 question form | 36 questions asking individuals questions about their general health and wellness, not disease-specific | Month five | |
Primary | Short Form, 36 question form | 36 questions asking individuals questions about their general health and wellness, not disease-specific | Month six | |
Primary | Withings Heartrate & Activity | Patient activity, sleep quality, and heart rate collected by the wearable watch | Continuously, for six months | |
Secondary | Heart rate variability | Measurement of individual's change in pulse via a smartphone's onboard camera | Week two | |
Secondary | Heart rate variability | Measurement of individual's change in pulse via a smartphone's onboard camera | Week three | |
Secondary | Heart rate variability | Measurement of individual's change in pulse via a smartphone's onboard camera | Week four | |
Secondary | Heart rate variability | Measurement of individual's change in pulse via a smartphone's onboard camera | Week five | |
Secondary | Heart rate variability | Measurement of individual's change in pulse via a smartphone's onboard camera | Week six | |
Secondary | Heart rate variability | Measurement of individual's change in pulse via a smartphone's onboard camera | Week seven | |
Secondary | Heart rate variability | Measurement of individual's change in pulse via a smartphone's onboard camera | Week eight | |
Secondary | Heart rate variability | Measurement of individual's change in pulse via a smartphone's onboard camera | Week nine | |
Secondary | Heart rate variability | Measurement of individual's change in pulse via a smartphone's onboard camera | Week ten | |
Secondary | Heart rate variability | Measurement of individual's change in pulse via a smartphone's onboard camera | Week eleven | |
Secondary | Heart rate variability | Measurement of individual's change in pulse via a smartphone's onboard camera | Week twelve | |
Secondary | Heart rate variability | Measurement of individual's change in pulse via a smartphone's onboard camera | Week thirteen | |
Secondary | Heart rate variability | Measurement of individual's change in pulse via a smartphone's onboard camera | Week fourteen | |
Secondary | Heart rate variability | Measurement of individual's change in pulse via a smartphone's onboard camera | Week fifteen | |
Secondary | Heart rate variability | Measurement of individual's change in pulse via a smartphone's onboard camera | Week sixteen | |
Secondary | Heart rate variability | Measurement of individual's change in pulse via a smartphone's onboard camera | Week seventeen | |
Secondary | Heart rate variability | Measurement of individual's change in pulse via a smartphone's onboard camera | Week eighteen | |
Secondary | Heart rate variability | Measurement of individual's change in pulse via a smartphone's onboard camera | Week nineteen | |
Secondary | Heart rate variability | Measurement of individual's change in pulse via a smartphone's onboard camera | Week twenty | |
Secondary | Heart rate variability | Measurement of individual's change in pulse via a smartphone's onboard camera | Week twenty-one | |
Secondary | Heart rate variability | Measurement of individual's change in pulse via a smartphone's onboard camera | Week twenty-two | |
Secondary | Heart rate variability | Measurement of individual's change in pulse via a smartphone's onboard camera | Week twenty-three | |
Secondary | Heart rate variability | Measurement of individual's change in pulse via a smartphone's onboard camera | Week twenty-four | |
Secondary | Heart rate variability | Measurement of individual's change in pulse via a smartphone's onboard camera | Week twenty-five | |
Secondary | Heart rate variability | Measurement of individual's change in pulse via a smartphone's onboard camera | Week twenty-six |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03248518 -
Lessening the Impact of Fatigue in Inflammatory Rheumatic Diseases
|
N/A | |
Recruiting |
NCT05967520 -
JMKX000189 for Moderate to Severe Active Systemic Lupus Erythematosus
|
Phase 2 | |
Completed |
NCT02875691 -
Effect of Green Tea on Treatment of Lupus
|
Phase 2 | |
Completed |
NCT02922114 -
Comparison of the Clinical Examination and the Joint Ultrasonography in Lupus Patients
|
N/A | |
Withdrawn |
NCT01702038 -
Determining the Responses and Impact of Rituximab-instigated Cell Depletion on T Cells in People With SLE
|
Phase 2 | |
Terminated |
NCT00368264 -
TNF Blockade With Remicade in Active Lupus Nephritis WHO Class V (TRIAL )
|
Phase 2/Phase 3 | |
Completed |
NCT00094380 -
Treating Systemic Lupus Erythematosus (SLE) Patients With CTLA4-IgG4m (RG2077)
|
Phase 1/Phase 2 | |
Completed |
NCT00065806 -
Atherosclerosis Prevention in Pediatric Lupus Erythematosus (APPLE)
|
Phase 3 | |
Completed |
NCT00005436 -
Lupus Cohort--Thrombotic Events and Coronary Artery Disease
|
N/A | |
Recruiting |
NCT03543839 -
Trial of Belimumab in Early Lupus
|
Phase 4 | |
Completed |
NCT03098823 -
A Crossover Study to Compare RAYOS to IR Prednisone to Improve Fatigue and Morning Symptoms for SLE
|
Phase 4 | |
Recruiting |
NCT05899907 -
Efficacy and Safety of Telitacicept in Early SLE
|
Phase 4 | |
Completed |
NCT04956484 -
Belimumab In Early Systemic Lupus Erythematosus
|
Phase 4 | |
Completed |
NCT05326841 -
Effect of Cholecalciferol Supplementation on Disease Activity and Quality of Life of Systemic Lupus Erythematosus Patients .
|
Phase 3 | |
Completed |
NCT02655640 -
The Impact of Illness Perceptions on Health Related Outcomes in Patients With Lupus and Systemic Sclerosis
|
N/A | |
Completed |
NCT02034344 -
A Study of Skin and Systemic Biomarkers In Patients With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers
|
Phase 0 | |
Terminated |
NCT00089804 -
Study of LJP 394 in Lupus Patients With History of Renal Disease
|
Phase 3 | |
Completed |
NCT00071487 -
Safety and Efficacy Study of LymphoStat-B (Belimumab) in Subjects With Systemic Lupus Erythematosus (SLE)
|
Phase 2 | |
Completed |
NCT02349061 -
A Phase 2a, Efficacy and Safety Study of Ustekinumab in Systemic Lupus Erythematosus
|
Phase 2 | |
Recruiting |
NCT05636670 -
Assessment of Cognitive Function and Gut Microbiota Analysis in Real World Patients With Lupus Cerebrovascular Disease
|